Uri Sivan
Director/Board Member at Technion Research & Development Foundation Ltd.
Profile
Uri Sivan is the founder of Onecell Medical Ltd.
He is currently working as a Director at Technion Research & Development Foundation Ltd.
Uri Sivan active positions
| Companies | Position | Start |
|---|---|---|
Technion Research & Development Foundation Ltd.
 Technion Research & Development Foundation Ltd. Miscellaneous Commercial ServicesCommercial Services Technion Research & Development Foundation Ltd. supports technical research and engineering development projects. The company was founded on February 19, 1952 and is headquartered in Haifa, Israel. | Director/Board Member | 2019-09-30 |
Former positions of Uri Sivan
| Companies | Position | End |
|---|---|---|
Onecell Medical Ltd.
 Onecell Medical Ltd. Medical SpecialtiesHealth Technology Onecell Medical Ltd. is an Israeli company that specializes in personalized cell-therapy for cancer treatment. The company is based in Raanana, Israel. The company aims to engineer personalized cancer-specific immune cells for each patient based on their genetic information, which will be significantly more effective in minimizing the chance for relapse. The company was founded by Elad Brod and Uri Sivan. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Technion Research & Development Foundation Ltd.
Technion Research & Development Foundation Ltd. Miscellaneous Commercial ServicesCommercial Services Technion Research & Development Foundation Ltd. supports technical research and engineering development projects. The company was founded on February 19, 1952 and is headquartered in Haifa, Israel. | Commercial Services |
Onecell Medical Ltd.
Onecell Medical Ltd. Medical SpecialtiesHealth Technology Onecell Medical Ltd. is an Israeli company that specializes in personalized cell-therapy for cancer treatment. The company is based in Raanana, Israel. The company aims to engineer personalized cancer-specific immune cells for each patient based on their genetic information, which will be significantly more effective in minimizing the chance for relapse. The company was founded by Elad Brod and Uri Sivan. | Health Technology |
- Stock Market
- Insiders
- Uri Sivan
